Results 21 to 30 of about 21,448 (153)
Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
Therapeutic Advances in Psychopharmacology, 2022 Background: Aripiprazole is a third-generation antipsychotic agent with acceptable efficacy and a good safety profile. Previous studies have indicated the therapeutic serum concentration of aripiprazole to be 100 to 350 ng/ml; however, most of these ...
Yun Tien +3 more
doaj +1 more source
Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats. [PDF]
PLoS ONE, 2015 Aripiprazole is a wide-used antipsychotic drug with therapeutic effects on both positive and negative symptoms of schizophrenia, and reduced side-effects.
Bo Pan +4 more
doaj +1 more source
A case of marked improvement in pareidolia in untreated schizophrenia following antipsychotic treatment. [PDF]
PCN RepAbstract Background Pareidolia, the tendency to perceive meaningful images within ambiguous visual patterns, is commonly observed in neurodegenerative disorders and schizophrenia. Owing to the limited number of studies, the characteristics of pareidolia accompanying schizophrenia remain unclear.
Kato T +8 more
europepmc +2 more sources
Frontiers in PsychiatryBackgroundThe present study aimed to investigate the drug–drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics.Research design and methodsA total of 119 patients with ...
Cun Zhang +19 more
doaj +1 more source
FEBS Open Bio, 2019 Drug repositioning has garnered attention as an alternative strategy to the discovery and development of novel anticancer drug candidates. In this study, we screened 321 FDA‐approved drugs against nonirradiated and irradiated MCF‐7 cells, revealing that ...
Hyounji Lee +3 more
doaj +1 more source
SAGE Open Medical Case Reports, 2017 Objectives: The efficacy of a partial agonist for the dopamine D 2 receptor, aripiprazole, for catatonia in schizophrenia has been reported. Methods: We report distinct clinical courses in challenging aripiprazole to treat residual mutism after severe ...
Katsumasa Muneoka +2 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale +5 more
wiley +1 more source
Persistent hiccups due to aripiprazole: a case report and review of the literature
Frontiers in PharmacologyIntroduction: Aripiprazole, a commonly prescribed antipsychotic, has been rarely associated with the onset of hiccups. This study aims to elucidate the prevalence, risk factors, and management of aripiprazole-induced hiccups.Methods: We report a case of ...
Yaoyin Zhang +11 more
doaj +1 more source
Aripiprazole induced severe parkinsonism: a case report
Neuropsychiatric Investigation, 2015 Aripiprazole, a D2 and 5-HT1A receptor partial agonist and 5-HT2A receptor antagonist, is an atypical antipsychotic. Previous studies indicated that the rate of extrapyramidal symptoms caused by aripiprazole is very close to that of placebo.
İkbal İNANLI +3 more
doaj +1 more source